Related Experiment Video
Updated: Nov 19, 2025
04:33
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
983
Mobile App Use in Adults with Comorbid Type 2 Diabetes and Depression
Diane Orr Chlebowy1, Mary-Beth Coty1, Adrian Lauf2
1School of Nursing, University of Louisville, Louisville, KY, USA.
Western Journal of Nursing Research
|January 30, 2021
Summary
Adults with type 2 diabetes (T2D) and depression are open to using mobile health (mHealth) apps for managing their condition. Younger individuals with advanced degrees showed higher likelihoods of using diabetes-specific apps.
Area of Science:
- Digital Health
- Behavioral Science
- Clinical Informatics
Background:
- Comorbid type 2 diabetes (T2D) and depression present significant management challenges.
- Mobile health (mHealth) apps offer potential for integrated self-management support.
- Understanding user adoption factors is crucial for effective mHealth interventions.
Purpose of the Study:
- To assess smartphone and mHealth app usage among adults with comorbid T2D and depression.
- To determine interest and intent to use mHealth applications for diabetes management.
- To identify demographic factors influencing app adoption in this population.
Main Methods:
- A preliminary study surveyed 35 adults with comorbid T2D and depression.
- Participants completed a Demographic and Mobile App Survey and the CESD-R-10.
- Statistical analysis identified predictors of mobile app usage.
Main Results:
- A majority (65.7%) used mobile apps, with 46.7% comfortable using them.
- Few used health apps (17.1%) or diabetes-specific apps (8.6%).
- Younger age (<55) and higher education (graduate degree) predicted higher app use and diabetes-specific app use.
Conclusions:
- Adults with T2D and depression demonstrate amenability towards mHealth app utilization.
- Targeted strategies may enhance adoption of diabetes management apps in this demographic.
- Further research is warranted to optimize mHealth interventions for comorbid T2D and depression.
Related Concept Videos
01:27Depressive Disorders: MDD and Dysthymia
334
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
334
01:22Diabetes Mellitus: Type 2 and Gestational
3.8K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.8K
01:18Depression: Overview
569
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
569
01:22Diabetes Mellitus: Overview and Type I Subtype
4.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.3K
01:15Diabetes: Symptoms, Diagnosis, and Complications
1.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.5K
01:15Diabetes: Management and Pharmacotherapy
707
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
707